REALYSA aims to constitute a platform for innovative and ambitious research projects. To date, the REALYSA data and collection of biological samples have been and will used for the following research projects.

Last update: 10 SEPT 2025.

If you would like to submit a research project with the cohort, you will find more information here.

REA-GIP STUDY: representativeness of -LIFE REALYSA cohort of Pointou_Charentes (POITIERS-NIORT) compared to a population cohort from the POITOU-CHARENTES general cancer registry
SynthEID study: developing a method for constituting a reference group of patients aged 80 years and over with a diffuse large B-cell lymphoma
SENIOR IPI: Prognostic score for patients with diffuse large B-cell lymphomas over 80 years of age
ReCLASS MZL Study – REdefining the CLassification Algorithm and Staging System in Marginal Zone Lymphoma
BIDIFLY Study (BIOLOGICAL AND IMAGING DATA INTEGRATION FOR FOLLICULAR LYMPHOMA RESEARCH
Study of the quality of life of patients with mantle celle lymphoma
INTENSIFY Study – Integrated Analysis of High-Risk Large B-cell Lymphomas
REALY-T study: Description and management of peripheral T-cell lymphomas
REALYSA- Comparing the Efficacy of CAR-T Cells to Standard of Care in Refractory and Relapsed Large B-cell Lymphomas
GLYPHOSATE Mutation Study – Analysis of the genetic and epigenetic effects of glyphosate-based herbicides on the organism
GREY ZONE Study: Description and Management of Patients with Grey Zone Lymphoma
REALYSA-EBV study: Clinico-biological characteristics of patients with EBV-positive large B-cell lymphoma
BURKITT Study: Description and Management of Patients with Burkitt’s Lymphoma
CLARITY Study: Description and Management of Large B-cell Lymphomas
FL study: description and management of patients with follicular lymphoma
HR-Low-IPI: Prognostic Score Study for Diffuse Large B-cell Lymphomas
PANORAMA HL study: Description and management of patients with Hodgkin’s lymphoma
Evaluation of the presence and impact of concomitant diseases on the management of patients with lymphoma: linking REALYSA clinical data to health insurance data
PMBL Study: Description and Management of Patients with Primary Mediastinal Large B-Cell Lymphoma
SYNTH-L study: developing a method for constituting a reference group of patients with Hodgkin lymphoma
ELKIN study: Identifying the biological reasons for treatment failures for Hodgkin’s lymphoma in elderly patients
ANTICANCER study: links between cancer and immune aging
ESCAPE study: Impact of a biomarker on the evolution of T-cell lymphomas
REALMA – Characteristics and Management of Patients with Marginal Zone Lymphoma
MCL_TOUR : Description and management of mantle cell lymphomas
FRENCH CONNECT study – Study of tumor DNA for the management of lymphomas
Description and management of diffuse lymphomas receiving a 2nd line of therapy
Description and management of diffuse lymphomas receiving a 3rd line of therapy
COMPARISON OF PATIENTS INCLUDED AND NOT INCLUDED IN REALYSA AT LYON-SUD HOSPITAL
Description and care pathway for people over 60 years of age with diffuse large B-cell lymphoma
PELYCANO study – impact of pesticide exposure in patients with diffuse large B-cell lymphoma
Research project on anaplastic large cell lymphoma
Use of Brentuximab Vedotin before transplant – HL
Brentuximab Vedotin Usage Report 2021 and 2022
REALY-QoL – Quality of Life of patients with lymphoma in France
Research project on T-cell lymphoma
POLARYSA – a study on diffuse large B-cell lymphoma
Brentuximab Vedotin Usage Report 2019 and 2020